Scorpion Therapeutics
Boston
About Scorpion Therapeutics
Scorpion Therapeutics is a clinical-stage oncology company specializing in precision medicine for cancer patients. It develops targeted small-molecule drugs to interact with validated cancer targets. It aims to leverage its platform to advance a broad pipeline of wholly-owned, optimized compounds across molecules targeting validated oncogene targets, molecules for previously undruggable targets, and molecules for novel cancer targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $420.0M
- Funding stage: M&A
- Last round: Series C (Jul 2024)
- Website: scorpiontx.com
- Phone: (212) 841-1015
Industries & Categories
Biotechnology, Health Care, Life Science, Oncology, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/scorpion-therapeutics-101561 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.